IDEAYA Biosciences (IDYA) Beats Q4 Earnings Estimates by $0.04

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly earnings results on February 17, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $-0.94, beating the consensus estimate of $-0.98 by $0.04 per share. Revenue came in at $10.9M, beating the estimate of $9.2M.

IDEAYA Biosciences's stock moved following the earnings release. The stock currently trades at $30.73 with a market capitalization of $2.9B.